{"id":311,"date":"2016-11-04T01:10:02","date_gmt":"2016-11-04T01:10:02","guid":{"rendered":"http:\/\/pulmonologi.fk.uns.ac.id\/?page_id=311"},"modified":"2021-03-03T01:18:43","modified_gmt":"2021-03-03T01:18:43","slug":"grant-research","status":"publish","type":"page","link":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/penelitian\/grant-research\/","title":{"rendered":"Grant Research","raw":"Grant Research"},"content":{"rendered":"<p>TAHUN 2013<br \/>\n1. MOLECULAR ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV), TORQUE TENO VIRUS (TTV} AND TUBERCULOSIS IN HIV PATIENTS<\/p>\n<p>2. Open label, Randomized, Multicenter Study to Compare Clinical Efficacy and Safety of Levofloxacine (750 mg IV \u2013 Oral Once Daily) to Moxifloxacine (400mg IV \u2013 Oral Once Daily) in Hospitalized Patients with Moderate to Severe Community-Aquared Pneumonia in Indonesia (Protocol No.CVA-07-016)(Daichi)<\/p>\n<p>3. A Clinical Outcomes Study to compare the effect of Fluticasone Furoate\/Vilanterol Inhalation Powder 100\/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and history of orat increased risk for cardiovaskuler disease.  PAREXEL Number 110812, 090828 (SUMMIT STUDY)<\/p>\n<p>4. A randomized, pararel-group, open-label, multicentre, 3-month phase IV, efficacy and tolerability study of budesonide\/folmoterol (Symbicort\u00ae Turbuhaler\u00ae 160\/4.5\u00b5g\/inhalation, 2 inhalation twice daily) added to tiotropium (Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily)  compared with tiotropium ((Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily) alone in severe chronic obstructive pulmonary disease (COPD) patients. (SECURE I)<\/p>\n<p>5. Kloning dan karakteristik molekuler patogen blood bone untuk pembuatan kit diagnostik dan vaksin berbasis isolat lokal.<\/p>\n<p>TAHUN 2014<br \/>\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients<\/p>\n<p>2. Metode dan bahan untuk deteksi molekuler HIV grup M,N,O, dan P berbasis isolat Indonesia<\/p>\n<p>3. Molecular epidemiology of HBV, HCV, HDV, HTLV \u00bd and GBV C in Central Java HIV Patients<\/p>\n<p>4. Protocol SAS115359: A Safety and Efficacy Study of Inhaled Fluticasone Propionate\/ Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma(ASMALABA)<\/p>\n<p>5. A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific  Immunotherapy with Racotumomab Plus Best  Support Treatment in Patients with Advanced Non Small Cell Lung Cancer<\/p>\n<p>TAHUN 2015<br \/>\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients<\/p>\n<p>2. Metode dan bahan untuk deteksi molekuler virus hepatitis  C berbasis isolat Indonesia<\/p>\n<p>3. Polimorfisme HLA-C dan HLA-G untuk prediksi respon ketahanan terhadap infeksi patogen blood borne sebagai dasar pengembangan vaksin, obat dan kit diagnosis informasi genomik lokal<\/p>\n<p>4. Kloning, karakterisasi molekuler dan kontruksi plasmid ekspresor protein esensial HIV isolat Jawa Tengah untuk pengembangan kit diagnostik, vaksin dan terapi HIV berbasis isolat lokal<\/p>\n","protected":false,"raw":"TAHUN 2013\r\n1. MOLECULAR ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV), TORQUE TENO VIRUS (TTV} AND TUBERCULOSIS IN HIV PATIENTS\r\n          \r\n2. Open label, Randomized, Multicenter Study to Compare Clinical Efficacy and Safety of Levofloxacine (750 mg IV \u2013 Oral Once Daily) to Moxifloxacine (400mg IV \u2013 Oral Once Daily) in Hospitalized Patients with Moderate to Severe Community-Aquared Pneumonia in Indonesia (Protocol No.CVA-07-016)(Daichi)\r\n\r\n3. A Clinical Outcomes Study to compare the effect of Fluticasone Furoate\/Vilanterol Inhalation Powder 100\/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and history of orat increased risk for cardiovaskuler disease.  PAREXEL Number 110812, 090828 (SUMMIT STUDY)\r\n\r\n4. A randomized, pararel-group, open-label, multicentre, 3-month phase IV, efficacy and tolerability study of budesonide\/folmoterol (Symbicort\u00ae Turbuhaler\u00ae 160\/4.5\u00b5g\/inhalation, 2 inhalation twice daily) added to tiotropium (Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily)  compared with tiotropium ((Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily) alone in severe chronic obstructive pulmonary disease (COPD) patients. (SECURE I)\r\n\r\n5. Kloning dan karakteristik molekuler patogen blood bone untuk pembuatan kit diagnostik dan vaksin berbasis isolat lokal.\r\n\r\nTAHUN 2014\r\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients\r\n\r\n2. Metode dan bahan untuk deteksi molekuler HIV grup M,N,O, dan P berbasis isolat Indonesia\r\n\r\n3. Molecular epidemiology of HBV, HCV, HDV, HTLV \u00bd and GBV C in Central Java HIV Patients\r\n\r\n4. Protocol SAS115359: A Safety and Efficacy Study of Inhaled Fluticasone Propionate\/ Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma(ASMALABA)\r\n\r\n5. A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific  Immunotherapy with Racotumomab Plus Best  Support Treatment in Patients with Advanced Non Small Cell Lung Cancer\r\n\r\nTAHUN 2015\r\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients\r\n\r\n2. Metode dan bahan untuk deteksi molekuler virus hepatitis  C berbasis isolat Indonesia\r\n\r\n3. Polimorfisme HLA-C dan HLA-G untuk prediksi respon ketahanan terhadap infeksi patogen blood borne sebagai dasar pengembangan vaksin, obat dan kit diagnosis informasi genomik lokal\r\n\r\n4. Kloning, karakterisasi molekuler dan kontruksi plasmid ekspresor protein esensial HIV isolat Jawa Tengah untuk pengembangan kit diagnostik, vaksin dan terapi HIV berbasis isolat lokal\r\n"},"excerpt":{"rendered":"","protected":false,"raw":""},"author":1,"featured_media":0,"parent":1727,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_en_post_content":"TAHUN 2013\r\n1. MOLECULAR ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV), TORQUE TENO VIRUS (TTV} AND TUBERCULOSIS IN HIV PATIENTS\r\n          \r\n2. Open label, Randomized, Multicenter Study to Compare Clinical Efficacy and Safety of Levofloxacine (750 mg IV \u2013 Oral Once Daily) to Moxifloxacine (400mg IV \u2013 Oral Once Daily) in Hospitalized Patients with Moderate to Severe Community-Aquared Pneumonia in Indonesia (Protocol No.CVA-07-016)(Daichi)\r\n\r\n3. A Clinical Outcomes Study to compare the effect of Fluticasone Furoate\/Vilanterol Inhalation Powder 100\/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and history of orat increased risk for cardiovaskuler disease.  PAREXEL Number 110812, 090828 (SUMMIT STUDY)\r\n\r\n4. A randomized, pararel-group, open-label, multicentre, 3-month phase IV, efficacy and tolerability study of budesonide\/folmoterol (Symbicort\u00ae Turbuhaler\u00ae 160\/4.5\u00b5g\/inhalation, 2 inhalation twice daily) added to tiotropium (Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily)  compared with tiotropium ((Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily) alone in severe chronic obstructive pulmonary disease (COPD) patients. (SECURE I)\r\n\r\n5. Kloning dan karakteristik molekuler patogen blood bone untuk pembuatan kit diagnostik dan vaksin berbasis isolat lokal.\r\n\r\nTAHUN 2014\r\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients\r\n\r\n2. Metode dan bahan untuk deteksi molekuler HIV grup M,N,O, dan P berbasis isolat Indonesia\r\n\r\n3. Molecular epidemiology of HBV, HCV, HDV, HTLV \u00bd and GBV C in Central Java HIV Patients\r\n\r\n4. Protocol SAS115359: A Safety and Efficacy Study of Inhaled Fluticasone Propionate\/ Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma(ASMALABA)\r\n\r\n5. A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific  Immunotherapy with Racotumomab Plus Best  Support Treatment in Patients with Advanced Non Small Cell Lung Cancer\r\n\r\nTAHUN 2015\r\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients\r\n\r\n2. Metode dan bahan untuk deteksi molekuler virus hepatitis  C berbasis isolat Indonesia\r\n\r\n3. Polimorfisme HLA-C dan HLA-G untuk prediksi respon ketahanan terhadap infeksi patogen blood borne sebagai dasar pengembangan vaksin, obat dan kit diagnosis informasi genomik lokal\r\n\r\n4. Kloning, karakterisasi molekuler dan kontruksi plasmid ekspresor protein esensial HIV isolat Jawa Tengah untuk pengembangan kit diagnostik, vaksin dan terapi HIV berbasis isolat lokal\r\n","_en_post_name":"grant-research","_en_post_excerpt":"","_en_post_title":"Grant Research","_id_post_content":"TAHUN 2013\r\n1. MOLECULAR ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV), TORQUE TENO VIRUS (TTV} AND TUBERCULOSIS IN HIV PATIENTS\r\n          \r\n2. Open label, Randomized, Multicenter Study to Compare Clinical Efficacy and Safety of Levofloxacine (750 mg IV \u2013 Oral Once Daily) to Moxifloxacine (400mg IV \u2013 Oral Once Daily) in Hospitalized Patients with Moderate to Severe Community-Aquared Pneumonia in Indonesia (Protocol No.CVA-07-016)(Daichi)\r\n\r\n3. A Clinical Outcomes Study to compare the effect of Fluticasone Furoate\/Vilanterol Inhalation Powder 100\/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and history of orat increased risk for cardiovaskuler disease.  PAREXEL Number 110812, 090828 (SUMMIT STUDY)\r\n\r\n4. A randomized, pararel-group, open-label, multicentre, 3-month phase IV, efficacy and tolerability study of budesonide\/folmoterol (Symbicort\u00ae Turbuhaler\u00ae 160\/4.5\u00b5g\/inhalation, 2 inhalation twice daily) added to tiotropium (Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily)  compared with tiotropium ((Spiriva\u2122 18\u00b5g\/inhalation, 1 inhalation once daily) alone in severe chronic obstructive pulmonary disease (COPD) patients. (SECURE I)\r\n\r\n5. Kloning dan karakteristik molekuler patogen blood bone untuk pembuatan kit diagnostik dan vaksin berbasis isolat lokal.\r\n\r\nTAHUN 2014\r\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients\r\n\r\n2. Metode dan bahan untuk deteksi molekuler HIV grup M,N,O, dan P berbasis isolat Indonesia\r\n\r\n3. Molecular epidemiology of HBV, HCV, HDV, HTLV \u00bd and GBV C in Central Java HIV Patients\r\n\r\n4. Protocol SAS115359: A Safety and Efficacy Study of Inhaled Fluticasone Propionate\/ Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma(ASMALABA)\r\n\r\n5. A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific  Immunotherapy with Racotumomab Plus Best  Support Treatment in Patients with Advanced Non Small Cell Lung Cancer\r\n\r\nTAHUN 2015\r\n1. Molecular analysis of Human Immunodeficiency Virus (HIV), Torque Teno Virus (TTV) and Tuberculosis in HIV patients\r\n\r\n2. Metode dan bahan untuk deteksi molekuler virus hepatitis  C berbasis isolat Indonesia\r\n\r\n3. Polimorfisme HLA-C dan HLA-G untuk prediksi respon ketahanan terhadap infeksi patogen blood borne sebagai dasar pengembangan vaksin, obat dan kit diagnosis informasi genomik lokal\r\n\r\n4. Kloning, karakterisasi molekuler dan kontruksi plasmid ekspresor protein esensial HIV isolat Jawa Tengah untuk pengembangan kit diagnostik, vaksin dan terapi HIV berbasis isolat lokal\r\n","_id_post_name":"hibah-penelitian","_id_post_excerpt":"","_id_post_title":"Hibah Penelitian","edit_language":"en","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_joinchat":[],"footnotes":""},"class_list":["post-311","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/comments?post=311"}],"version-history":[{"count":8,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/311\/revisions"}],"predecessor-version":[{"id":659,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/311\/revisions\/659"}],"up":[{"embeddable":true,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/1727"}],"wp:attachment":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/media?parent=311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}